Augmented cardiac growth hormone signaling in circadian-disrupted cardiomyopathy
- 1Department of Surgery, Division of Vascular Surgery, Washington University in St. Louis
- 2Department of Medicine, Division of Cardiology, Washington University School of Medicine
Abstract
Circadian disruption, including rotating shift work, social jet lag, and chronic sleep disturbance, is associated with increased cardiovascular risk and may promote cardiac remodeling. The molecular mechanisms connecting clock disruption to structural heart disease remain incompletely defined. This minireview advances the hypothesis that the growth hormone, GH, axis is an underrecognized endocrine mediator. GH secretion is time dependent, with most daily secretion occurring during early nocturnal sleep-in humans. Cardiomyocytes express GH receptors, and GH can activate Janus kinase 2, signal transducer and activator of transcription 5, phosphoinositide 3 kinase and Akt, and mitogen activated protein kinase and extracellular signal regulated kinase pathways that influence cardiac growth and metabolism. We propose that the cardiomyocyte molecular clock restricts GH responsiveness to circadian phases. REV ERBα is a plausible component of this restraint, but direct cardiomyocyte evidence is lacking. Circadian disruption may increase or mistime myocardial GH signaling, promoting hypertrophy, fibrosis, and metabolic inflexibility. The strongest support comes from cardiomyocyte specific Bmal1 deficient mice, which show increased GH induced cardiac STAT5 phosphorylation, increased cardiac Igf1 expression, and remodeling. Reduction of GH receptor gene dosage partially attenuates this phenotype, supporting a causal contribution of cardiac GH signaling. Nevertheless, genetic clock ablation is not equivalent to environmental circadian misalignment in shift work or chronic sleep disruption. We critically evaluate the components of this proposed clock-GH-heart axis, identify unresolved questions, and outline experiments and chronopharmacological strategies to test whether restoring temporal control of GH signaling can prevent pathological remodeling while preserving physiological GH action.
Related
- Graph-augmented transformer networks and explainable AI for economic impact forecasting in disrupted supply chains
- Dual cardiac amyloidosis with AL cardiomyopathy and ATTR cardiomyopathy in systemic AL amyloidosis: Recommendation for a myocardial histology-based diagnosis
- Research trends and hotspot analysis of sudden cardiac death in hypertrophic cardiomyopathy : A bibliometric analysis
- Artificial Intelligence-Enhanced Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy: Diagnosis, Phenotypic Characterization, and Risk Prediction
- Oral administration of Angiotensin-(1-7) included in hydroxypropyl β-cyclodextrin attenuates cardiac hypertrophy and inflammation in a mouse model of Takotsubo cardiomyopathy
BibTeX
@article{ibrahim2026augmented,
title = {{Augmented cardiac growth hormone signaling in circadian-disrupted cardiomyopathy}},
author = {Dina Ibrahim and Ravi Sonkar},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1982446},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1982446/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Augmented cardiac growth hormone signaling in circadian-disrupted cardiomyopathy
AU - Dina Ibrahim
AU - Ravi Sonkar
PY - 2026
DA - 2026/10/20
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1982446
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1982446/full
AB - Circadian disruption, including rotating shift work, social jet lag, and chronic sleep disturbance, is associated with increased cardiovascular risk and may promote cardiac remodeling. The molecular mechanisms connecting clock disruption to structural heart disease remain incompletely defined. This minireview advances the hypothesis that the growth hormone, GH, axis is an underrecognized endocrine mediator. GH secretion is time dependent, with most daily secretion occurring during early nocturnal sleep-in humans. Cardiomyocytes express GH receptors, and GH can activate Janus kinase 2, signal transducer and activator of transcription 5, phosphoinositide 3 kinase and Akt, and mitogen activated protein kinase and extracellular signal regulated kinase pathways that influence cardiac growth and metabolism. We propose that the cardiomyocyte molecular clock restricts GH responsiveness to circadian phases. REV ERBα is a plausible component of this restraint, but direct cardiomyocyte evidence is lacking. Circadian disruption may increase or mistime myocardial GH signaling, promoting hypertrophy, fibrosis, and metabolic inflexibility. The strongest support comes from cardiomyocyte specific Bmal1 deficient mice, which show increased GH induced cardiac STAT5 phosphorylation, increased cardiac Igf1 expression, and remodeling. Reduction of GH receptor gene dosage partially attenuates this phenotype, supporting a causal contribution of cardiac GH signaling. Nevertheless, genetic clock ablation is not equivalent to environmental circadian misalignment in shift work or chronic sleep disruption. We critically evaluate the components of this proposed clock-GH-heart axis, identify unresolved questions, and outline experiments and chronopharmacological strategies to test whether restoring temporal control of GH signaling can prevent pathological remodeling while preserving physiological GH action.
SN - 1663-9812
ER -